☆ 4.6 Letter

Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study

THORAX (2011)

Journal

THORAX

Volume 66, Issue 3, Pages 260-261

Publisher

B M J PUBLISHING GROUP

DOI: 10.1136/thx.2010.157032

Keywords

-

Categories

Respiratory System

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Multidisciplinary Sciences

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020

Carla Colombo, Gianfranco Alicandro, Valeria Dacco, Vanessa Gagliano, Letizia Corinna Morlacchi, Rosaria Casciaro, Giovanna Pisi, Michela Francalanci, Raffaele Badolato, Elisabetta Bignamini, Barbara Messore, Maria Cristina Lucanto, Giuseppina Leonetti, Massimo Maschio, Marco Cipolli

Summary: In patients with cystic fibrosis, SARS-CoV-2 infection resulted in relatively mild symptoms and outcomes, with no significant differences observed between those who tested positive and negative for the virus. Fever, cough, asthenia, and dyspnea were the most commonly reported symptoms, and 50% of cases required hospitalization but none needed ICU admission.

PLOS ONE (2021)

Add to Collection

Article Respiratory System

Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study

Sabina Anna Guler, Seo Am Hur, Michael K. Stickland, Patrick Brun, Luc Bovet, Anne E. Holland, Janet Bondarenko, Nathan Hambly, Joshua Wald, Nima Makhdami, Michael Kreuter, Rainer Gloeckl, Inga Jarosch, Benjamin Tan, Kerri A. Johannson, S. Ainslie McBride, Kaissa De Boer, Jacqueline S. Sandoz, Kelly Sun, Deborah Assayag, Surya P. Bhatt, Julie Morisset, Vincent Ferraro, Chris Garvey, Pat G. Camp, Christopher J. Ryerson

Summary: Improvement in physical performance during pulmonary rehabilitation is associated with better survival in patients with fibrotic ILD. Participation in at least 80% of planned outpatient PR sessions is linked to a 33% lower risk of death.

THORAX (2022)

Add to Collection

Article Virology

Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort study

Gerard Moreno, Raquel Carbonell, Emili Diaz, Ignacio Martin-Loeches, Marcos I. Restrepo, Luis F. Reyes, Jordi Sole-Violan, Maria Bodi, Laura Canadell, Juan Guardiola, Sandra Trefler, Loreto Vidaur, Elisabeth Papiol, Lorenzo Socias, Eudald Correig, Judith Marin-Corral, Alejandro Rodriguez

Summary: This study compared the effectiveness of prolonged versus standard course oseltamivir treatment in critically ill patients with severe influenza. The findings suggest that prolonged oseltamivir treatment can reduce ICU mortality and may have protective effects on survival compared to standard treatment. The study recommends extending the duration of oseltamivir treatment to 10 days, especially in higher-risk groups with prolonged viral shedding.

JOURNAL OF MEDICAL VIROLOGY (2023)

Add to Collection

Article Oncology

CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancer

Sofiane Allali, Matthieu Carton, Thomas Sarrade, Ophelie Querel, Alexandra Jacquet, Sofia Rivera, Youssef Ghannam, Karine Peignaux, Philippe Guilbert, Claire Chara-Brunaud, Julien Blanchecotte, David Pasquier, Severine Racadot, Celine Bourgier, Alain Labib, Julien Geffrelot, Ahmed Benyoucef, Francois Paris, Paul Cottu, Fabrice Andre, Youlia Kirova

Summary: Skin damage is a common and important toxicity during and after radiation therapy. This study found associations between skin erythema and obesity, type of surgery, axillary dissection, taxane-based chemotherapy, and the irradiation technique. Risk factors for fibrosis included age at diagnosis, obesity, tobacco, and the use of a boost. The use of IMRT technique decreased the occurrence of skin erythema.

INTERNATIONAL JOURNAL OF CANCER (2022)

Add to Collection

Article Gastroenterology & Hepatology

Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients

Martin Franck, Katharina John, Sherin Al Aoua, Monika Rau, Andreas Geier, Joern M. Schattenberg, Heiner Wedemeyer, Klaus Schulze-Osthoff, Heike Bantel

Summary: Serum levels of fibroblast growth factor 21 (FGF21) can differentiate between non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver (NAFL) patients, and predict the risk of significant fibrosis in NAFLD patients.

LIVER INTERNATIONAL (2023)

Add to Collection

Article Nutrition & Dietetics

Vitamin D Status and Risk of Cystic Fibrosis-Related Diabetes: A Retrospective Single Center Cohort Study

Yiqing Peng, Malinda Wu, Jessica A. Alvarez, Vin Tangpricha

Summary: Cystic fibrosis-related diabetes (CFRD) affects up to half of CF patients by adulthood, primarily caused by pancreatic dysfunction. This study found that vitamin D deficiency increases the risk of developing CFRD in adults with CF, and maintaining a serum 25(OH)D concentration above 20 ng/mL may decrease this risk.

NUTRIENTS (2021)

Add to Collection

Article Immunology

Distinguishing COVID-19 from seasonal influenza in patients under age 65 years-a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics

Wen Zhong, Yisong Wu, Wenxiang Yue, Jiabin Fang, Baosong Xie, Nengluan Xu, Ming Lin, Xiongpeng Zhu, Zhijun Su, Yusheng Chen, Hong Li, Hongru Li

Summary: This study explores the differences in clinical characteristics between 2009 pandemic influenza A (H1N1) and SARS-CoV-2 Omicron infections in patients under 65 years old. The results indicate that there are significant differences in clinical manifestations between the two groups, which have important implications for clinical practice.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study

Hend Ibrahim Shousha, Shimaa Afify, Rabab Maher, Noha Asem, Eman Fouad, Ehab F. Mostafa, Mohammed A. Medhat, Amr Abdalazeem, Hazem Elmorsy, Miriam M. Aziz, Rateba S. Mohammed, Mohamed Ibrahem, Hassan Elgarem, Dalia Omran, Mohamed Hassany, Bassem Elsayed, Ahmed Y. Abdelaziz, Mohamed El Kassas

Summary: Most Egyptian patients with COVID-19 did not develop severe liver injury. Independent factors affecting mortality included supplementary vitamin C intake, lung consolidation, ICU admission, and FIB-4 score.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Bacterial Pulmonary Co-Infections on ICU Admission: Comparison in Patients with SARS-CoV-2 and Influenza Acute Respiratory Failure: A Multicentre Cohort Study

Gregoire Delhommeau, Niccolo Buetti, Mathilde Neuville, Shidasp Siami, Yves Cohen, Virginie Laurent, Bruno Mourvillier, Jean Reignier, Dany Goldgran-Toledano, Carole Schwebel, Stephane Ruckly, Etienne de Montmollin, Bertrand Souweine, Jean-Francois Timsit, Claire Dupuis

Summary: This study compared the prognosis of patients admitted to an ICU for influenza pneumonia and for SARS-CoV-2 pneumonia. It found that SARS-CoV-2 pneumonia was associated with a higher risk of mortality compared to influenza pneumonia. Additionally, bacterial pulmonary co-infections on admission were not associated with patient survival rates or an increased risk of ventilator-associated pneumonia.

BIOMEDICINES (2022)

Add to Collection

Article Infectious Diseases

Burden of influenza A (H1N1)pdm09 infection among tuberculosis patients: a prospective cohort study

Gulshan Umbreen, Abdul Rehman, Muhammad Avais, Chanda Jabeen, Shakera Sadiq, Rubab Maqsood, Hamad Bin Rashid, Saira Afzal, Mamoona Chaudhry

Summary: This study aimed to estimate the burden of influenza A (H1N1)pdm09 virus infection among human tuberculosis patients and the general population. The results showed that individuals from the TB cohort had a higher incidence of influenza A (H1N1)pdm09 compared to the general population, suggesting that they should be prioritized for influenza vaccination.

BMC INFECTIOUS DISEASES (2023)

Add to Collection

Article Critical Care Medicine

Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis

Willis S. Bowman, Chad A. Newton, Angela L. Linderholm, Megan L. Neely, Janelle Vu Pugashetti, Bhavika Kaul, Vivian Vo, Gabrielle A. Echt, William Leon, Rupal J. Shah, Yong Huang, Christine Kim Garcia, Paul J. Wolters, Justin M. Oldham

Summary: This study aims to identify plasma biomarkers of progressive fibrosing interstitial lung disease (ILD) and develop a proteomic signature to predict this phenotype. The study identified 17 plasma biomarkers associated with progressive fibrosing ILD and developed a proteomic signature that can differentiate between high-risk and low-risk patients in clinical trials.

LANCET RESPIRATORY MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease

Eva Steinke, Olaf Sommerburg, Simon Y. Graeber, Cornelia Joachim, Christiane Labitzke, Gyde Nissen, Isabell Ricklefs, Isa Rudolf, Matthias V. Kopp, Anna-Maria Dittrich, Marcus A. Mall, Mirjam Stahl

Summary: This study is a prospective, longitudinal cohort study aimed at determining influencing factors of early cystic fibrosis (CF) lung disease through the combined analysis of clinical information and biomaterials. The primary endpoints are the lung clearance index and magnetic resonance imaging scores, while secondary endpoints include pulmonary exacerbations, infection with pro-inflammatory pathogens, and anthropometric data.

FRONTIERS IN MEDICINE (2023)

Add to Collection

Article Respiratory System

Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias

Noriyuki Enomoto, Sakae Homma, Naohiko Inase, Yasuhiro Kondoh, Takeshi Saraya, Hajime Takizawa, Yoshikazu Inoue, Hiroshi Ishii, Yoshio Taguchi, Shinyu Izumi, Yasuhiko Yamano, Yoshinori Tanino, Yasuhiko Nishioka, Mikio Toyoshima, Koshi Yokomura, Shiro Imokawa, Naoki Koshimizu, Takehisa Sano, Taisuke Akamatsu, Hiroshi Mukae, Motoyasu Kato, Naoki Hamada, Hirofumi Chiba, Shinobu Akagawa, Shigeo Muro, Hironori Uruga, Hiroyuki Matsuda, Yusuke Kaida, Miho Kanai, Kazutaka Mori, Masafumi Masuda, Hironao Hozumi, Tomoyuki Fujisawa, Yutaro Nakamura, Noriyoshi Ogawa, Takafumi Suda

Summary: This nationwide multicentre study prospectively evaluated 376 patients with IIP, finding that 18.6% of them met the IPAF criteria. Patients with IPAF were more likely to develop systemic autoimmune diseases, had fewer acute exacerbations of IIP, and showed better survival outcomes. Cluster analysis identified a subgroup with more autoimmune features, predominantly female, and with a better prognosis.

THORAX (2022)

Add to Collection

Article Infectious Diseases

Influenza-associated in-hospital mortality during the 2017/2018 influenza season: a retrospective multicentre cohort study in central Germany

Steve Roessler, Juliane Ankert, Michael Baier, Mathias W. Pletz, Stefan Hagel

Summary: This retrospective cohort study conducted at eight hospitals in Germany aimed to specify the influenza-associated in-hospital mortality during the 2017/2018 flu season, which was the most severe in the past 30 years in the country. It included 1560 patients and found an overall in-hospital mortality rate of 6.7%, with a higher rate of 22.4% in patients treated in the intensive care unit. The study also revealed that influenza was the immediate cause of death in 82.8% of the deceased patients.

INFECTION (2021)

Add to Collection

Article Immunology

Influenza Vaccination Effectiveness in Paediatric 'Healthy' Patients: A Population-Based Study in Italy

Anna Cantarutti, Elisa Barbieri, Fabio Didone, Antonio Scamarcia, Carlo Giaquinto, Giovanni Corrao

Summary: This study evaluates the effectiveness of the influenza vaccine (IV) in preventing influenza and influenza-like illness (ILI) in healthy children in Italy. The results show that the IV is highly effective in preventing influenza/ILI and there are no additional or prolonged effects.

VACCINES (2022)

Add to Collection

Article Respiratory System

VOCAL: An observational study of ivacaftor for people with cystic fibrosis and selected non-G551D-CFTR gating mutations *

Nicholas J. Simmonds, C. Kors van der Ent, Carla Colombo, Nils Kinnman, Cynthia DeSouza, Teja Thorat, Marci L. Chew, Keval Chandarana, Carlo Castellani

Summary: This study investigated the long-term effectiveness of ivacaftor on clinical outcomes and healthcare resource utilization in people with cystic fibrosis. The results showed significant improvements in lung function, nutritional status, and respiratory infections after ivacaftor treatment, along with a decrease in hospitalizations and antibiotic use.

JOURNAL OF CYSTIC FIBROSIS (2023)

Add to Collection

Article Rehabilitation

Limitations of the dichotomized 6-minute walk distance when computing lung allocation score for cystic fibrosis: a 16-year retrospective cohort study

Simone Gambazza, Federica Carta, Federico Ambrogi, Giacomo Bassotti, Anna Brivio, Maria Russo, Carla Colombo

Summary: This study aimed to investigate the clinical significance of the 6-minute walk test (6MWT) in candidates for lung transplantation (LTx) with cystic fibrosis (CF) for lung allocation score (LAS) calculation. The results showed a significant association between walked distance and the hazard ratio (HR) of LTx or death, but when used as an LAS calculation indicator, it does not provide useful information. Longitudinal trajectories of walked distance may provide complementary information about prognosis in individuals with CF.

DISABILITY AND REHABILITATION (2023)

Add to Collection

Article Gastroenterology & Hepatology

Effects of prolonged proton pump inhibitor treatment on nutritional status and respiratory infection risk in cystic fibrosis: A matched cohort study

Laura Zazzeron, Gianfranco Alicandro, Valeria Dacco, Chiara Lanfranchi, Anna Bulfamante, Calogero Sathya Sciarrabba, Fabiola Corti, Carla Colombo

Summary: This study found that the use of proton pump inhibitors (PPI) as adjuvant therapy in people with cystic fibrosis (pwCF) may increase the risk of respiratory infection and does not improve nutritional status.

DIGESTIVE AND LIVER DISEASE (2023)

Add to Collection

Article Endocrinology & Metabolism

Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting

Simone De Leo, Matteo Trevisan, Carla Colombo, Claudia Moneta, Noemi Giancola, Laura Fugazzola

Summary: This retrospective cohort study aimed to investigate the incidence, characteristics, and management of hypocalcemia in patients with advanced thyroid cancer treated with lenvatinib. The study found a higher incidence of hypocalcemia (24%) compared to the registration trial (6.9%). The hypocalcemia in this cohort was caused by both PTH-dependent and PTH-independent mechanisms.

THYROID (2023)

Add to Collection

Article Respiratory System

Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators

Carla Colombo, Grant A. Ramm, Anders Lindblad, Fabiola Corti, Luigi Porcaro, Federico Alghisi, Irina Asherova, Helen Evans, Nataliya Kashirskaya, Elena Kondratyeva, Peter J. Lewindon, Isabelle de Monestrol, Mark Oliver, Chee Y. Ooi, Rita Padoan, Sahana Shankar, Gianfranco Alicandro

Summary: Cystic-fibrosis-related liver disease (CFLD) is a variable phenotype of CF. CFTR modulator therapies, elexacaftor, tezacaftor, and ivacaftor (ETI), and ivacaftor (IVA), are available for CF patients. Genetic eligibility evaluation showed that 13% of patients without CFLD and 11% of patients with severe CFLD are not eligible for ETI or IVA therapy. Ineligible patients cannot benefit from these new treatments.

JOURNAL OF CYSTIC FIBROSIS (2023)

Add to Collection

Article Pediatrics

Nutritional Status and Circulating Levels of Fat-Soluble Vitamins in Cystic Fibrosis Patients: A Cohort Study and Evaluation of the Effect of CFTR Modulators

Michela Francalanci, Vito Terlizzi, Cristina Fevola, Giulia Di Rosa, Valentina Pierattini, Elena Roselli, Paolo Bonomi, Maria Chiara Cavicchi, Valeria Galici, Anna Silvia Neri, Chiara Bianchimani, Silvia Campana, Daniela Dolce, Novella Ravenni, Erica Camera, Tommaso Orioli, Giovanni Taccetti

Summary: The study aims to assess nutritional status and serum levels of fat-soluble vitamins and evaluate the efficacy of modulators on these parameters. The results indicate that a small proportion of patients have malnutrition and insufficient vitamin D levels. Treatment with modulators can improve nutritional status and levels of fat-soluble vitamins.

CHILDREN-BASEL (2023)

Add to Collection

Article Pediatrics

A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening

Antonella Tosco, Diletta Marino, Sara Polizzi, Valentina Tradati, Rita Padoan, Claudia Giust, Benedetta Fabrizzi, Giovanni Taccetti, Lucia Merli, Vito Terlizzi

Summary: This study compared the psychological impact of inconclusive diagnosis of cystic fibrosis (CF) after positive newborn screening (NBS) on parents. The results showed high levels of anxiety, depression, and traumatic impact in both the group with inconclusive diagnosis (CRMS/CFSPID) and the group with clear diagnosis. Parents evaluated their children's health as nearly healthy.

CHILDREN-BASEL (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators

Vito Terlizzi, Emanuela Pesce, Valeria Capurro, Valeria Tomati, Mariateresa Lena, Cristina Pastorino, Renata Bocciardi, Federico Zara, Claudia Centrone, Giovanni Taccetti, Carlo Castellani, Nicoletta Pedemonte

Summary: This study described the clinical features of individuals carrying the S737F CFTR variant and evaluated its functional impact on CFTR protein as well as its responsiveness to CFTR modulators through ex vivo functional and molecular analyses. Clinical data were collected retrospectively for all individuals with at least one S737F CFTR variant followed at the CF Centre of Tuscany region (Italy). The study demonstrated varying levels of CF activity in ex vivo nasal epithelia, with some individuals showing reduced CFTR activity that could be rescued by treatment with CFTR modulators. In vitro analysis on bronchial cells expressing S737F-CFTR also showed modest impairment of channel activity, which was improved with treatment using ivacaftor alone or in combination with tezacaftor/elexacaftor. This study provides evidence for using ex vivo nasal epithelial cell models to evaluate CFTR function and assist clinicians in classifying individuals with discordance between clinical symptoms, sweat test, and genetic profile.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Gastroenterology & Hepatology

Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival

C. Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, Palak J. Trivedi, Christophe Corpechot, Adriaan J. van der Meer, Willem J. Lammers, Pier Maria Battezzati, Keith D. Lindor, Frederik Nevens, Kris Kowdley, Tony Bruns, Nora Cazzagon, Annarosa Floreani, Andrew L. Mason, Aliya Gulamhusein, Cyriel Y. Ponsioen, Marco Carbone, Ana Lleo, Marlyn J. Mayo, George N. Dalekos, Nikolaos K. Gatselis, Douglas Thorburn, Xavier Verhelst, Albert Pares, Maria-Carlota Londono, Harry L. A. Janssen, Pietro Invernizzi, Raj M. Vuppalanchi, Gideon M. Hirschfield, Bettina E. Hansen, Cynthia Levy

Summary: This study aimed to assess the POISE criteria for treatment response evaluation in patients with primary biliary cholangitis (PBC) and evaluate the utility of alkaline phosphatase (ALP) at six months as a predictor of insufficient response. The results showed that an ALP threshold of 1.9 x ULN at six months accurately identified non-responders.

LIVER INTERNATIONAL (2023)

Add to Collection

Review Pediatrics

Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment

Valeria Dacco, Gianfranco Alicandro, Alessandra Consales, Chiara Rosazza, Calogero S. Sciarrabba, Lisa Cariani, Carla Colombo

Summary: This study provides insights into Cepacia syndrome (CS), a rare but potentially lethal complication of Burkholderia cepacia complex (BCC) infection in cystic fibrosis (CF) patients. The study includes a systematic review of 18 cases of CS reported over the last 24 years, with a high mortality rate of 50%. The data are insufficient to determine the most effective therapeutic approach for CS.

PEDIATRIC PULMONOLOGY (2023)

Add to Collection

Article Health Care Sciences & Services

Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry

Simone Gambazza, Annalisa Orenti, Giovanna Pizzamiglio, Anna Zolin, Carla Colombo, Dario Laquintana, Federico Ambrogi, ECFSPR

Summary: This study aimed to understand the prognosis for people with cystic fibrosis (pwCF) on oxygen therapy (OT), evaluating the probability of lung transplantation (LTx) and death in pwCF with and without OT. The study found that OT is strongly associated with poor survival in pwCF, highlighting the importance of harmonizing CF care throughout European countries and minimizing the onset of pulmonary gas exchange abnormalities.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2023)

Add to Collection

Article Medicine, General & Internal

Concomitant Use of Elexacaftor/Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis

Sara Immacolata Orsini, Edoardo Marrani, Ilaria Pagnini, Giovanni Taccetti, Vito Terlizzi, Gabriele Simonini

Summary: Patients with cystic fibrosis can also have juvenile idiopathic arthritis, and this report describes the first pediatric case of a patient with cystic fibrosis, Basedow's disease, and juvenile idiopathic arthritis who received treatment with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) and anti-tumor necrosis factor alpha (anti-TNF alpha). The report suggests that this combination treatment is safe and effective for these patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Health Care Sciences & Services

Distribution of OGTT-Related Variables in Patients with Cystic Fibrosis from Puberty to Adulthood: An Italian Multicenter Study

Andrea Foppiani, Fabiana Ciciriello, Arianna Bisogno, Silvia Bricchi, Carla Colombo, Federico Alghisi, Vincenzina Lucidi, Maria Ausilia Catena, Mariacristina Lucanto, Andrea Mari, Giorgio Bedogni, Alberto Battezzati

Summary: This study aimed to describe the distribution and provide reference quartiles of OGTT-related variables in the Italian cystic fibrosis population. The results showed the deterioration of glucose tolerance and insulin secretion with age according to sex and pancreatic insufficiency, highlighting a deviation from linearity for patients 35 years of age.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Add to Collection

Review Endocrinology & Metabolism

Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature

Stefano Palomba, Carla Colombo, Andrea Busnelli, Donatella Caserta, Giovanni Vitale

Summary: This study comprehensively reviews the relationship between polycystic ovary syndrome (PCOS) and thyroid dysfunction by analyzing available evidence in nine main areas of interest. The results suggest that PCOS and thyroid disorders are closely related, and their coexistence may increase the reproductive and metabolic risk of patients. Regular screening for thyroid function and thyroid-specific autoantibodies in women with PCOS, particularly before and during pregnancy, is highly recommended.

FRONTIERS IN ENDOCRINOLOGY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.